Pulmonary hypertension associated with left-sided heart disease
Pulmonary hypertension associated with left-sided heart disease
复制标题
DOI：
10.1016/j.ccm.2006.12.001
复制
发表时间：
2007-03-01
影响因子：
5.7
通讯作者：
Oudiz, Ronald J.
中科院分区：
文献类型：
--
作者：
Oudiz, Ronald J.
肺动脉高压(PH)意味着左心病人预后不良。没有研究表明前列腺素类药物、内皮素拮抗剂和磷酸二酯酶-5抑制剂等PH药物有长期的益处。在某些情况下，可能需要谨慎使用PH药物。然而，出于理论和实践方面的考虑，任何正式建议都受到限制。
Pulmonary hypertension (PH) denotes a poor prognosis in patients with left-sided heart disease. No study has demonstrated long-term benefit from PH drugs such as prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors. In some cases, cautious use of PH drugs may be indicated. However, theoretic and practical concerns limit any formal recommendations.